Australian Trade Mark Search

Australian Trade Mark Search is the Australian Government’s trade mark search system.

Additional fields:

Trade mark 2030454

IR number 1483177
Words GEGANT
Image
Image description
Status protected: Registered/protected
Priority date 21 Dec 2018 (Convention)
Classes 5, 10, 42, 44
Kind Word
Dates
Renewal due 05 Jun 2029
Registration advertised / published 04 Feb 2020
Entered on Register 04 Feb 2020
Acceptance advertised / published 25 Nov 2019
Acceptance 25 Nov 2019
IR notification 15 Aug 2019
Filing 05 Jun 2019
Registered from 05 Jun 2019

Owner Address for service
ITM Medical Isotopes GmbH
KINGS PATENT & TRADE MARKS ATTORNEYS PTY LTD

IR Contact

WINTER, BRANDL, FÜRNISS, HÜBNER, RÖSS, KAISER, POLTE PARTNERSCHAFT PATENT- UND RECHTSANWALTSKANZLEI


Goods & Services
Class 5: Radiopharmaceutical preparations for use in oncology, namely radiopharmaceuticals containing Gallium-68 for treating and diagnosing tumours; Gallium-68 compounds, including 68-Ga chlorides; Gallium-68 for use in the field of targeted radionuclide therapy to diagnose cancers, in particular prostate cancer and neuroendocrine tumours; Gallium-68 compounds, including 68-Ga peptide chelates, in particular 68-Ga-Dotatoc and 68-Ga-Dotatate, 68-Ga salts, in particular 68-Ga chlorides; Gallium-68 for use as radiotracers in pet scans or combined pet/ct scans.
Class 10: Ge-68/Ga-68 radionuclide generators for pharmaceutical purposes as source of radionuclides being positron emitters in the field of Positron Emission Tomography - Computed Tomography (PET/CT).
Class 42: Scientific and technological services and research on radiopharmaceutical products, namely 68-Ga products for use in medicine for third parties, namely services relating to radiopharmaceuticals for the therapy and diagnosis of diseases and services relating to radiopharmaceuticals coupled to somatostatin analogues for the diagnosis and treatment of tumours.
Class 44: Pharmaceutical advice in relation to radiopharmaceutical products, namely 68-Ga products for use in medicine for third parties, namely advice in relation to radiopharmaceuticals for the therapy and diagnosis of diseases, in particular tumour diseases; advice in relation to radiopharmaceuticals coupled to somatostatin analogues and advice in relation to the manufacture of personalised radiopharmaceutical products containing 68-Ga for use in medicine.

Endorsements

The applicant has advised that the words in the Mark have no meaning in English


Convention details
Date 21 Dec 2018
Number 018003752
Country EUROPEAN UNION INTELLECTUAL PROPERTY OFFICE (EUIPO)

Indexing constituents
Word Image